Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1328

Related Citations for PubMed (Select 15337652)

1.

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.

Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.

Am J Psychiatry. 2004 Sep;161(9):1620-5.

PMID:
15337652
2.
3.

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.

Mamo D, Kapur S, Shammi CM, Papatheodorou G, Mann S, Therrien F, Remington G.

Am J Psychiatry. 2004 May;161(5):818-25.

PMID:
15121646
4.
5.
6.

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.

Remington G, Mamo D, Labelle A, Reiss J, Shammi C, Mannaert E, Mann S, Kapur S.

Am J Psychiatry. 2006 Mar;163(3):396-401.

PMID:
16513859
7.

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.

Gefvert O, Lundberg T, Wieselgren IM, Bergström M, Långström B, Wiesel F, Lindström L.

Eur Neuropsychopharmacol. 2001 Apr;11(2):105-10.

PMID:
11313155
8.

Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.

Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R.

Am J Psychiatry. 2001 Feb;158(2):311-4.

PMID:
11156818
9.

In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.

Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.

Eur J Nucl Med. 1999 Aug;26(8):862-8.

PMID:
10436199
10.

Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S.

Am J Psychiatry. 2007 Apr;164(4):630-7.

PMID:
17403977
11.

Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.

Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.

Psychiatry Clin Neurosci. 2009 Aug;63(4):529-37. doi: 10.1111/j.1440-1819.2009.01982.x. Epub 2009 May 22.

PMID:
19496999
12.

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.

Tauscher J, Küfferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S.

Psychopharmacology (Berl). 2002 Jun;162(1):42-9. Epub 2002 May 16.

PMID:
12107616
13.

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S.

Am J Psychiatry. 1998 Jul;155(7):921-8.

PMID:
9659858
14.

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.

Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.

Psychopharmacology (Berl). 1997 Oct;133(4):323-8.

PMID:
9372530
15.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
16.

Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.

Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.

Psychopharmacology (Berl). 2000 Jun;150(2):132-40.

PMID:
10907666
17.

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.

Nordström AL, Nyberg S, Olsson H, Farde L.

Arch Gen Psychiatry. 1998 Mar;55(3):283-4. No abstract available.

PMID:
9510228
18.

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.

Bressan RA, Erlandsson K, Jones HM, Mulligan R, Flanagan RJ, Ell PJ, Pilowsky LS.

Am J Psychiatry. 2003 Aug;160(8):1413-20.

PMID:
12900302
20.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):600-10.

PMID:
16585434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk